FLOXONIL
Main information
- Trade name:
- FLOXONIL 10 TZ TAB
- Active ingredient:
- Ciprofloxacin,Tinidazole
- Available from:
- Marc Lab
- Dosage:
- 500,600;MG
- Pharmaceutical form:
- TZ TAB
- Composition:
- 10
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
3-2-2014
Danish Pharmacovigilance Update 28 November 2013
In this issue of Danish Pharmacovigilance Update: Ciprofloxacin and the risk of tendon disorders, risk of blood clots from the use of the cancer medicine ponatinib and reporting of adverse reactions to the Danish Health and Medicines Authority.
Danish Medicines Agency
31-1-2019
Opinion/decision on a Paediatric investigation plan (PIP): Ciprofloxacin (hydrochloride), decision type: , therapeutic area: , PIP number: P/0253/2018
Opinion/decision on a Paediatric investigation plan (PIP): Ciprofloxacin (hydrochloride), decision type: , therapeutic area: , PIP number: P/0253/2018
Europe - EMA - European Medicines Agency
21-1-2019
Ciprofloxacin (systemic use): List of nationally authorised medicinal products - PSUSA/00000775/201801
Ciprofloxacin (systemic use): List of nationally authorised medicinal products - PSUSA/00000775/201801
Europe - EMA - European Medicines Agency
21-1-2019
Ciprofloxacin (systemic use): CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00000775/201801
Ciprofloxacin (systemic use): CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00000775/201801
Europe - EMA - European Medicines Agency
10-9-2018
Ciprofloxacin hydrochloride / hydrocortisone: List of nationally authorised medicinal products - PSUSA/00000774/201711
Europe - EMA - European Medicines Agency